Remove topics dna
article thumbnail

Evolving Perspectives: USPTO Call for Comments on Patent Eligibility Comes to a Close (Part 1)

IPilogue

Patent and Trademarks Office (USPTO) closed the public comment period on the contentious topic of patent eligibility. While a vast realm of things can be patented, software and medical devices are frequently hot topics when discussing patent eligibility. On October 15, 2021, the U.S Current State.

Patent 105
article thumbnail

Never Too Late: If you missed the IPKat last week!

The IPKat

A Kat in desperate need of a coffee GuestKat Gabriele Girardello shared with us the trends and topics covered at the “Pharma & Biotech Patent Litigation” conference in Amsterdam, which he attended on 14-16 March 2022. The decision was reported and commented on by our GuestKat Rose Hughes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Overview of the S. 3 landscape on patenting biotechnology inventions in India

SpicyIP

Notably, in Myriad , genomic DNA was held to be a ‘product of nature’ and ineligible for patent protection. But complementary DNA (cDNA) that is created with human intervention in labs was held to be patentable subject matter. Prometheus Laboratories, Ass’n for Molecular Pathology v. Myriad Genetics and Alice Corp. CLS Bank Int’l.

article thumbnail

First substantive decision of the UPC Court of Appeal overturns preliminary injunction in NanoString v 10x Genomics (UPC_CoA_335/2023)

The IPKat

Case Background: Munich Local Divisions strikes patentee friendly approach The patent at issue ( EP 4108782 ), exclusively licensed to 10x Genomics by Harvard, relates to methods and compositions for detecting analytes such as DNA or protein molecules in cell and tissue samples.

article thumbnail

Around the IP Blogs

The IPKat

In addition, potential and tangible intersections between intellectual property and these trending topics were recently discussed by The Trademark Lawyer Magazine. The EPO's Opposition Division recently discussed a case involving a patent on DNA sequencing owned by the University of Berkeley and the University of Vienna, among others.

article thumbnail

Guest Post: Jillian Grennan, Charting New Paths in Innovation: Reflections from Harvard’s Innovation Economics Conference

Patently-O

The evidence shows women are less frequently credited as authors on articles and patents, a pattern echoing historical instances like Rosalind Franklin’s unacknowledged work on the DNA structure and Jennifer Doudna’s worries about diminished recognition in the CRISPR development.

Inventor 105
article thumbnail

Got Milk? Forget about Patent Eligibility

Patently-O

The Federal Circuit weighed in on the amorphous topic of subject matter eligibility in the recent opinion ChromaDex, Inc., In Myriad , the isolation of specific DNA fragments was found to be patent ineligible. He has an extensive background in chemistry and food science. Elysium Health, Inc. , — F.4th 4th —, Docket No.

Patent 56